Serum VEGF-A and Tumor Vessel VEGFR-2 Levels Predict Survival in Caucasian but Not Asian Patients Undergoing Resection for Gastric Adenocarcinoma

BACKGROUND: Clinical trials of agents targeting the vascular endothelial growth factor A (VEGF-A) pathway in gastric adenocarcinoma (GA) suggest that these therapies may have varying efficacy in different races. METHODS: VEGF-A in serum and/or VEGF receptor 2 (VEGFR-2) in CD31-positive tumor vessels...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Ann Surg Oncol
Hauptverfasser: Park, Do Joong, Seo, An Na, Yoon, Changhwan, Ku, Geoffrey Y., Coit, Daniel G., Strong, Vivian E., Suh, Yun-Suhk, Lee, Hye Seung, Yang, Han-Kwang, Kim, Hyung-Ho, Yoon, Sam S.
Format: Artigo
Sprache:Inglês
Veröffentlicht: 2015
Schlagworte:
Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4872865/
https://ncbi.nlm.nih.gov/pubmed/26259755
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1245/s10434-015-4790-y
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge